ArticleDiscover oncology2024

Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma.

Mo Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.